Literature DB >> 17032379

Dynamic vascular analysis shows a hyperemic flow pattern in sickle cell disease.

Pornpatr Ausavarungnirun1, Hernan Sabio, Jongyeol Kim, Charles H Tegeler.   

Abstract

BACKGROUND: By the age of 20 years, 10% of sickle cell disease (SCD) patients have experienced a stroke. It is unclear if SCD stroke is due primarily to hemodynamic effects of intracranial stenosis, or metabolic failure from anemia. Transcranial Doppler ultrasound (TCD) identifies a SCD subgroup with high stroke risk, but high mean flow velocity (MFV) can be due to stenosis or high flow rate, as with metabolic hyperemia of severe anemia. Dynamic Vascular Analysis (DVA; New Health Sciences, Inc., Bethesda, MD) is a new way to analyze TCD data, with potential to separate structural from metabolic causes of high MFV.
METHODS: Eighty SCD patients, regardless of hemoglobin genotypes, aged 2 to 22 years, without clinical stroke or transient ischemic attack (TIA), who had TCD (1/1/02 to 1/1/04) as part of routine outpatient clinical follow-up, with both the TCD report and study videotape available, were included. Waveforms were reviewed and marked by protocol, and DVA indices calculated including MFV, pulsatility index (PI), systolic acceleration (SA), dynamic flow index (DFI), dynamic pressure index (DPI), and dynamic compliance index (DCI). Mean and standard deviation were defined for the whole group, and for four subgroups, by age.
RESULTS: MFV, DFI, and DPI were highest at 6- to 9-year-olds, declining thereafter. The 14- to 22-year-old group was also compared to a group of healthy young athletes (15- to 22 years old). SCD patients had higher MFV, lnSA, DFI, DPI, and lower PI and DCI in most segments, suggesting global hyperemia.
CONCLUSION: This is the first report of cross-sectional results of DVA in a cohort of SCD outpatients without prior clinical stroke (TIA). These results suggest hyperemia without significant focal intracranial stenosis. There were also differences between asymptomatic SCD and young athletes, and the MFV, DFI, and DPI were highest at the age of 6 to 9 years, decreasing as age increased.

Entities:  

Mesh:

Year:  2006        PMID: 17032379     DOI: 10.1111/j.1552-6569.2006.00053.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  6 in total

1.  Sickle cell disease: ratio of blood flow velocity of intracranial to extracranial cerebral arteries--initial experience.

Authors:  Mikolaj A Pawlak; Jaroslaw Krejza; Wojciech Rudzinski; Janet L Kwiatkowski; Rebecca Ichord; Abbas F Jawad; Maciej Tomaszewski; Elias R Melhem
Journal:  Radiology       Date:  2009-05       Impact factor: 11.105

2.  Sickle cell disease: reference values and interhemispheric differences of nonimaging transcranial Doppler blood flow parameters.

Authors:  M Arkuszewski; J Krejza; R Chen; J L Kwiatkowski; R Ichord; R Zimmerman; K Ohene-Frempong; L Desiderio; E R Melhem
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

3.  Sickle cell anemia: reference values of cerebral blood flow determined by continuous arterial spin labeling MRI.

Authors:  M Arkuszewski; J Krejza; R Chen; E R Melhem
Journal:  Neuroradiol J       Date:  2013-05-10

4.  Sickle cell disease and transcranial Doppler imaging: inter-hemispheric differences in blood flow Doppler parameters.

Authors:  Jaroslaw Krejza; Rong Chen; Grzegorz Romanowicz; Janet L Kwiatkowski; Rebecca Ichord; Michal Arkuszewski; Robert Zimmerman; Kwaku Ohene-Frempong; Lisa Desiderio; Elias R Melhem
Journal:  Stroke       Date:  2010-11-18       Impact factor: 7.914

5.  Evaluation of SWI in children with sickle cell disease.

Authors:  A M Winchell; B A Taylor; R Song; R B Loeffler; P Grundlehner; J S Hankins; W C Wang; R J Ogg; C M Hillenbrand; K J Helton
Journal:  AJNR Am J Neuroradiol       Date:  2013-11-21       Impact factor: 3.825

6.  Removal of Arterial Vessel Contributions in Susceptibility-Weighted Images for Quantification of Normalized Visible Venous Volume in Children with Sickle Cell Disease.

Authors:  Adam M Winchell; Ruitian Song; Ralf B Loeffler; Winfred C Wang; Jane S Hankins; Kathleen J Helton; Claudia M Hillenbrand
Journal:  J Healthc Eng       Date:  2017-08-28       Impact factor: 2.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.